Iota Sciences
Delivering single cells to advance research and medicine
Understanding how individual cells behave is key to developing new medicines, diagnostics, and therapies.
Iota Sciences has created a novel microfluidics platform that shapes tiny droplets of fluid to identify single cells and create monoclonal colonies. The technology makes single cell cloning cheaper, faster and more reliable – enabling simpler, and more scalable research into cell biology therapies.
Sector
HealthTech